Continuation of Profitable Performance and Material Reduction in Non-Core Policies-In-Force

Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and short bowel syndrome (SBS) with intestinal failure

Proof-of-concept studies of crofelemer for MVID and SBS planned for 2024

Sumitomo Corporation Power & Mobility, a 100% subsidiary of Sumitomo Corporation and Electrovaya have expanded their sales partnership with a formal supply agreement with the intention to supply battery modules to a leading Japanese construction equipment OEM

Grid Metals Intersects High-Grade Lithium Values Including 4.7% Li₂O At Maiden Falcon West Drill Program

A lawsuit is pending for certain investors in Amplitude, Inc. (NASDAQ:AMPL) shares. NASDAQ:AMPL investors should contact the Shareholders Foundation.

A deadline is coming up on May 20th in the lawsuit that was filed for certain investors in share of the Chemours Company (NYSE: CC) and NYSE: CC investors should contact the Shareholders Foundation. 

A lawsuit is pending for certain investors in Sunnova Energy International Inc. (NYSE: NOVA) shares and NYSE: NOVA investors should contact the Shareholders Foundation, Inc